⌘K
Loading ticker…
As of 2026-08-24, ArriVent BioPharma, Inc. Common Stock (AVBP) has a 3-month relative strength percentile of 59 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.8%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
AVBP is held by 19 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $5M notional. Top 3 carry $11M.
Held by 38 ETFs · $103M across latest filings · largest weight 0.94% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $5M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| SBIO | 0.85% | $1M | +0.24 pp |
| CANC | 0.73% | $1M | +0.15 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $921K |
| +0.01 pp |
| ONEQ | 0.01% | $691K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $545K | — |
| AVSC | 0.02% | $487K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $85K | — |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVBP Jan avg: 8.89% median: 7.75% win: 100% σ: 2.52% n: 3 2024-01-29 → 2026-07-31 | AVBP Feb avg: -5.06% median: -0.05% win: 33% σ: 10.63% n: 3 2024-01-29 → 2026-07-31 | AVBP Mar avg: -12.78% median: -17.08% win: 33% σ: 11.67% n: 3 2024-01-29 → 2026-07-31 | AVBP Apr avg: 14.08% median: 14.98% win: 67% σ: 21.15% n: 3 2024-01-29 → 2026-07-31 | AVBP May avg: 4.94% median: -0.05% win: 33% σ: 10.95% n: 3 2024-01-29 → 2026-07-31 | AVBP Jun avg: 4.26% median: 2.45% win: 67% σ: 9.73% n: 3 2024-01-29 → 2026-07-31 | AVBP Jul avg: -2.16% median: -10.38% win: 33% σ: 17.61% n: 3 2024-01-29 → 2026-07-31 | AVBP Aug avg: 10.03% median: 10.03% win: 50% σ: 17.01% n: 2 2024-01-29 → 2026-07-31 (current) | AVBP Sep avg: -7.79% median: -7.79% win: 0% σ: 6.07% n: 2 2024-01-29 → 2026-07-31 | AVBP Oct avg: 13.18% median: 13.18% win: 100% σ: 16.50% n: 2 2024-01-29 → 2026-07-31 | AVBP Nov avg: 12.29% median: 12.29% win: 100% σ: 14.40% n: 2 2024-01-29 → 2026-07-31 | AVBP Dec avg: -11.69% median: -11.69% win: 0% σ: 0.86% n: 2 2024-01-29 → 2026-07-31 |